Freedom from Price Gouging Act
Official title: To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4663: Freedom from Price Gouging Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4663/
"H.R. 4663: Freedom from Price Gouging Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4663/.
H.R. 4663, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4663/.
[H.R. 4663: Freedom from Price Gouging Act](https://openamerica.io/bill/116-HR-4663/)